These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11493246)

  • 21. Comparative study of four different pharmacokinetic computer programs: case study of a factor VIII preparation.
    Pascual B; Montoro JB
    Eur J Clin Pharmacol; 1997; 52(1):59-64. PubMed ID: 9143869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate
    Megías-Vericat JE; Bonanad S; Haya S; Cid AR; Marqués MR; Monte-Boquet E; Pérez-Alenda S; Bosch P; Querol F; Poveda JL
    Haemophilia; 2019 May; 25(3):e215-e218. PubMed ID: 30866068
    [No Abstract]   [Full Text] [Related]  

  • 23. Relationship between factor VIII replacement therapy and joint damage in severe haemophilia.
    Lowe GD
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S3-5. PubMed ID: 9351528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and pharmacodynamics of SCT800, a new recombinant FVIII, in hemophilia A mice.
    Gu RL; Liu L; Xie LZ; Gai WL; Cao SS; Meng ZY; Gan H; Wu ZN; Li J; Zheng Y; Zhu XX; Dou GF
    Acta Pharmacol Sin; 2016 Mar; 37(3):408-14. PubMed ID: 26806305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffuse alveolar haemorrhage with severe haemophilia.
    Chandrakala S; Jijina F; Ghosh K
    Haemophilia; 2010 Nov; 16(6):962-4. PubMed ID: 20491960
    [No Abstract]   [Full Text] [Related]  

  • 26. High responding factor VIII inhibitors in mild haemophilia - is there a link with recent changes in clinical practice?
    White B; Cotter M; Byrne M; O'Shea E; Smith OP
    Haemophilia; 2000 Mar; 6(2):113-5. PubMed ID: 10781199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATE®)--an open-label, sequential dosing pharmacokinetic study in patients with severe haemophilia A.
    Martinowitz U; Bjerre J; Brand B; Klamroth R; Misgav M; Morfini M; Santagostino E; Tiede A; Viuff D
    Haemophilia; 2011 Nov; 17(6):854-9. PubMed ID: 21443634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bleeding in haemophilia during massive treatment with anti-haemophilic globulin (author's transl)].
    Sutor AH; Jesdinsky-Buscher C
    Dtsch Med Wochenschr; 1975 May; 100(21):1183-6. PubMed ID: 1132328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful perioperative prophylaxis with susoctocog alfa in a patient with acquired haemophilia A: A case study.
    Buczma A; Baran B; Korwin M; Odnoczko E; Windyga J
    Haemophilia; 2022 Mar; 28(2):e39-e41. PubMed ID: 34878208
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term patterns of safety and efficacy of bleeding prophylaxis with turoctocog alfa (NovoEight(®) ) in previously treated patients with severe haemophilia A: interim results of the guardian(™) 2 extension trial.
    Ozelo M; Misgav M; Abdul Karim F; Lentz SR; Martin-Salces M; Matytsina I; Saugstrup T; Santagostino E
    Haemophilia; 2015 Sep; 21(5):e436-9. PubMed ID: 26058730
    [No Abstract]   [Full Text] [Related]  

  • 31. Haemorrhage into a popliteal cyst: an unusual complication of haemophilia A.
    Rodriguez V; Shaughnessy WJ; Schmidt KA; Slaby JA; Gilchrist GS; Pruthi RK
    Haemophilia; 2002 Sep; 8(5):725-8. PubMed ID: 12199689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and evaluation of a generic population pharmacokinetic model for standard half-life factor VIII for use in dose individualization.
    McEneny-King A; Chelle P; Foster G; Keepanasseril A; Iorio A; Edginton AN
    J Pharmacokinet Pharmacodyn; 2019 Oct; 46(5):411-426. PubMed ID: 31104228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FVIII replacement in 12-day-old newborn with haemophilia A requiring surgical repair of D transposition of great arteries.
    Kuzmanovic M; Stajevic M; Vukomanovic V; Serbic O; Jankovic B
    Haemophilia; 2011 Sep; 17(5):821-2. PubMed ID: 21435118
    [No Abstract]   [Full Text] [Related]  

  • 34. North-eastern Brazilian recommendations for the nurse professional role on the pharmacokinetic-assisted prophylaxis individualization for haemophilia A.
    de Morais Costa NC; Costa ÍM; Guimarães TMR; de Souza HP; Casaretto ES; de Medeiros TC; Barbosa SM; Matos AIEL; Oliveira EG; Camelo RM
    Haemophilia; 2020 May; 26(3):e120-e123. PubMed ID: 32026514
    [No Abstract]   [Full Text] [Related]  

  • 35. A United Kingdom Haemophilia Centre Doctors' Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A.
    Richards M; Williams M; Chalmers E; Liesner R; Collins P; Vidler V; Hanley J;
    Br J Haematol; 2010 May; 149(4):498-507. PubMed ID: 20230411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporarily successful eradication therapy in acquired haemophilia with high inhibitor titer: a case report with a new protocol.
    Ilonczai P; Schlammadinger A; Oláh Z; Rázsó K; Bereczky Z; Boda Z
    Thromb Haemost; 2008 Jul; 100(1):149-50. PubMed ID: 18612550
    [No Abstract]   [Full Text] [Related]  

  • 37. Porcine recombinant factor VIII: an additional weapon to handle anti-factor VIII antibodies.
    Mannucci PM; Franchini M
    Blood Transfus; 2017 Jul; 15(4):365-368. PubMed ID: 27483484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New therapies for hemophilia.
    Pipe SW
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):650-656. PubMed ID: 27913542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population pharmacokinetics of recombinant factor VIII:C (ReFacto) in adult HIV-negative and HIV-positive haemophilia patients.
    Karafoulidou A; Suarez E; Anastasopoulou I; Katsarou O; Kouramba A; Kotsi P; Zografidis A; Lukas JC
    Eur J Clin Pharmacol; 2009 Nov; 65(11):1121-30. PubMed ID: 19641914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PK-guided personalized prophylaxis with Nuwiq
    Lissitchkov T; Rusen L; Georgiev P; Windyga J; Klamroth R; Gercheva L; Nemes L; Tiede A; Bichler J; Knaub S; Belyanskaya L; Walter O; Pasi KJ
    Haemophilia; 2017 Sep; 23(5):697-704. PubMed ID: 28452151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.